Aktis Oncology

Updated: January 09, 2026

CEO Matthew Roden

Country: USA | Funding: $331M (+)

Website: https://www.aktisoncology.com/

Aktis Oncology develops radiopharmaceutical treatments for solid tumors.

Competitors